Introduction

Acanthocheilonemiasis, a parasitic infection caused by the nematode Acanthocheilonema perstans, presents a formidable diagnostic challenge in tropical medicine. The insidious nature of this infection, often manifesting with nonspecific symptoms or even asymptomatically, renders it a diagnostic enigma. As a clinician practicing in a region endemic for this parasite, I have firsthand experience with the frustrations of accurately identifying this condition. The parasite's predilection for sub-Saharan Africa compounds the diagnostic dilemma, as it may not be a primary consideration for clinicians working in other geographic regions. Given the overlap in symptoms with numerous non-tropical diseases and the lack of highly specific diagnostic tests, acanthocheilonemiasis often remains underdiagnosed. This paper aims to illuminate the complexities surrounding the diagnosis of this elusive infection, exploring available diagnostic modalities and differential considerations.

Signs and symptoms

Acanthocheilonemiasis often begins without noticeable symptoms, allowing the infection time to develop.

Over time, individuals may experience:   

• Skin irritation: Itching (pruritus) is a common symptom
• Pain: Abdominal and chest pain can occur
• Swelling: Localized swelling (edema) may develop in various body parts
• Muscle discomfort: Muscle aches (myalgias) are often reported

In more severe cases, medical examinations might reveal:

• Abnormal immune responses: The body's immune system may overreact
• Lung inflammation: Pleuritis, inflammation of the lung lining, can occur
• Liver and spleen enlargement: Hepatosplenomegaly, an abnormal increase in liver and spleen size, is possible
• Blood abnormalities: Elevated eosinophil levels, a type of white blood cell, might be present
• Heart inflammation: Pericarditis, inflammation of the heart's outer layer, can develop in rare cases

It's important to note that these symptoms can overlap with other conditions, making accurate diagnosis challenging.¹

Differential diagnosis

The challenge in diagnosing acanthocheilonemiasis lies in its overlapping symptoms with other medical conditions, particularly other parasitic infections.¹

One group of diseases often confused with acanthocheilonemiasis is filariasis. Both are parasitic infections caused by nematode worms. However, a key distinction lies in their mode of transmission. Acanthocheilonemiasis is spread by small flies, while filariasis is transmitted by mosquitoes. Filariasis can manifest in various forms, including lymphadenopathy (swollen lymph nodes), mumu (a local swelling), loiasis (Calabar swellings), onchocerciasis (river blindness), and elephantiasis (severe limb or genital swelling). These conditions share some symptoms with acanthocheilonemiasis, making differential diagnosis essential.¹

Beyond filariasis, other tropical and non-tropical diseases can mimic the symptoms of acanthocheilonemiasis. For instance, abdominal and chest pain, itchy skin, and muscle discomfort are common complaints in various parasitic and non-parasitic infections. This broad symptom overlap underscores the need for comprehensive diagnostic testing to accurately identify the underlying cause.¹

To differentiate acanthocheilonemiasis from these similar conditions, healthcare providers must rely on a detailed medical history, including travel history to endemic regions, physical examination, and specific laboratory tests. These investigations help to pinpoint the causative agent and guide appropriate treatment.¹

Given the complexities involved, early and accurate diagnosis is crucial for effective management and prevention of complications associated with acanthocheilonemiasis and related conditions.

Population at risk

Individuals residing in or frequently visiting regions where the disease is prevalent are at heightened risk of contracting acanthocheilonemiasis. These endemic areas are primarily located in Central Africa and parts of South America. Consequently, local populations in these regions have a higher likelihood of infection compared than visitors or tourists.

It's important to note that the parasite does not discriminate based on gender or age, affecting both males and females throughout their lifespan.¹

Factors such as occupation and lifestyle can also influence exposure risk. Those working or spending extended periods outdoors in rural areas are more likely to encounter the infected insects that transmit the parasite.

Treatment options

While there's no universally effective treatment for all parasitic infections, acanthocheilonemiasis can often be managed successfully. The primary approaches are medication and, in severe cases, surgery.   

Antiparasitic drugs form the cornerstone of treatment. Ivermectin and diethylcarbamazine (DEC) are commonly prescribed medications to target and reduce the worm population, thereby alleviating associated symptoms. These drugs are particularly effective in cases where only eggs and larvae are present.¹  

However, when the worm burden is substantial and life-threatening, surgery may be necessary to physically remove the parasites. This invasive procedure is typically followed by an antiparasitic medication to eliminate any remaining parasites.¹   

It's important to emphasize that the choice of treatment depends on the severity of the infection, the patient's overall health, and the specific characteristics of the parasitic burden. Close monitoring by healthcare professionals is essential to evaluate treatment efficacy and adjust the treatment plan as needed.

While these treatments can be effective in managing acanthocheilonemiasis, research into new and improved therapeutic options continues.

Neglected tropical diseases

Neglected Tropical Diseases (NTDs) have historically been underprioritized due to a complex interplay of factors. Their often asymptomatic nature and lengthy incubation periods make them difficult to detect and link to mortality. Furthermore, these diseases are predominantly found in isolated, impoverished regions, hindering access to treatment and prevention efforts.²

The disproportionate impact of NTDs on the world's poorest populations has contributed significantly to their neglect. Global health initiatives have primarily focused on high-profile diseases like HIV/AIDS, tuberculosis, and malaria, which garner greater public attention and funding due to their higher mortality rates. Additionally, the absence of prominent public figures championing the cause of NTDs has limited their visibility on the global health agenda.²

Social stigma is another major barrier to addressing NTDs. These diseases are often associated with poverty and poor hygiene, leading to discrimination and isolation for affected individuals. This stigma hinders help-seeking behavior and treatment adherence.²

The lack of economic incentives for pharmaceutical companies to develop treatments for NTDs has also hampered progress. Unlike diseases prevalent in wealthier nations, NTDs offer limited profit potential. Consequently, research and development efforts in this area are scarce. To address this gap, philanthropic organizations and governments have stepped in to fund NTD programs.²

It is crucial to recognize that NTDs are not confined to developing countries. These diseases also affect marginalized populations in developed nations, including the United States and Europe. Factors such as poverty, lack of awareness, and inadequate healthcare systems contribute to their persistence.²

Overcoming the challenges posed by NTDs requires a multi-faceted approach, including increased research and development, improved access to healthcare, targeted public health campaigns to address stigma, and sustained political commitment. By prioritizing these efforts, we can work towards eliminating the burden of NTDs on millions of people worldwide.²

Prevention of acanthocheilonemiasis

Preventing insect bites is the primary defense against acanthocheilonemiasis. Avoiding areas with high insect populations, especially during dusk and dawn when these insects are most active, is crucial. Additionally, employing insect control measures such as nets, repellents, and indoor spraying can provide added protection. Maintaining personal and environmental hygiene is also essential in preventing insect breeding.¹

For individuals already infected, preventing further complications is vital. This involves consistent use of insect repellent nets, wearing protective clothing, and maintaining proper personal and environmental hygiene. Removing potential breeding sites for insects, such as stagnant water and debris, is crucial. Community-wide efforts to eliminate breeding grounds can also be effective.¹  

Regular physical activity, proper wound care, and the installation of insect screens on doors and windows are additional preventive measures. By adopting these practices, individuals can significantly reduce their risk of contracting or experiencing complications from acanthocheilonemiasis.¹  

Conclusion

Acanthocheilonemiasis remains a diagnostic challenge due to its often asymptomatic presentation and overlapping symptoms with other tropical diseases. Accurate diagnosis is crucial for effective management and to prevent misattribution of symptoms to more common conditions. While advancements in diagnostic techniques have improved our ability to detect the parasite, challenges persist, particularly in resource-limited settings.

Differentiating acanthocheilonemiasis from other filarial infections and considering a broad spectrum of differential diagnoses is essential. A detailed medical history, including travel history to endemic regions, is crucial. Laboratory tests, such as blood examinations for eosinophilia and microscopic identification of microfilariae, can aid in diagnosis. However, the absence of a gold standard diagnostic test underscores the need for further research.

To address the burden of acanthocheilonemiasis, integrated control programs incorporating vector control, mass drug administration, and community engagement are essential. Strengthening healthcare systems in endemic regions is crucial for improving diagnostic capabilities and access to appropriate treatment. Additionally, continued research is needed to develop more sensitive and specific diagnostic tools, as well as effective interventions for this neglected tropical disease. By prioritizing acanthocheilonemiasis in public health agendas, we can move closer to controlling and ultimately eliminating its impact on affected populations.